✦ LIBER ✦

Pegylated interferon alpha 2b (PEG-IFN) plus ribavirin (RBV) versus pegylated interferon alpha 2b for chronic hepatits C in HIV patients

✍ Scribed by Cargnel, Antonietta; Angeli, Elena; Mainini, Annalisa; Gubertini, Guido; Giorgi, Riccardo; Orlando, Giovanna; Duca, Piergiorgio

Book ID: 121893812
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 242 KB
Volume: 124
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(03)83871-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of chronic hepatitis C in HIV

Treatment of chronic hepatitis C in HIV infected patients (PTS) with pegylated interferon alpha 2B (PEG-IFN) plus ribavirin (RBV) versus pegylated interferon alpha 2B

✍ A. Cargnel; E. Angeli; A. Mainini; A. Casella; G. Gubertini; R. Giorgi; G. Orlan 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 156 KB

Pegylated interferon alpha 2b (PEG IFN)

Pegylated interferon alpha 2b (PEG IFN) plus ribavirin (R) for treatment of chronic hepatitis C: optimization of ribavirin dose

✍ M. Manns; J.G. Mc Hutchison; S. Gordorn; V. Rustgi; M.V. Lee; M.L. Ling; M. Coha 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 51 KB

A randomized controlled trial of pegylat

A randomized controlled trial of pegylated-interferon alpha-2B + ribavirin vs interferon alpha-2B + ribavirin in HIV co-infected patients

✍ S. Pol; C. Perronne; F. Carrat; F. Banisadr; P. Morand; F. Lunel; E. Rosenthal 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 156 KB

Peginterferon alpha-2b plus ribavirin vs

Peginterferon alpha-2b plus ribavirin vs interferon alpha-2b plus ribavirin for chronic hepatitis C in HIV-coinfected patients

✍ M. Crespo; S. Sauleda; J. I. Esteban; A. Juarez; E. Ribera; A. L. Andreu; V. Fal 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 555 KB

751 The safety and efficacy of viramidin

751 The safety and efficacy of viramidine® plus pegylated interferon alpha-2B versus ribavirin plus pegylated interferon alpha-2B in therapy-naïve patients infected with HCV: Phase 3 results

✍ Y. Benhamou; P. Pockros; M. Rodrieuez-Torres; S. Gordon; M. Shiffinan; Y. Lurie; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Pegylated interferon alpha-2b plus ribav

Pegylated interferon alpha-2b plus ribavirin in patients with genotype 4 chronic hepatitis C: Some issues

✍ Ming-Lung Yu; Chia-Yen Dai; Jee-Fu Huang; Ming-Yen Hsieh; Wan-Long Chuang 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB 👁 2 views

accurate representation of the data is given in Table 1. 7. The major conclusion of this paper was that monitoring hepatitis C virus RNA levels and varying the duration of therapy can save resources without sacrificing rates of SVR. The authors used the Blackwelder test to test the noninferiority of